Marion Dorsch
CIK 1690460 · Chief Scientific Officer · last filed 2021-02-24
Marion Dorsch is a Chief Scientific Officer who has filed 19 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing, for BPMC, was dated Feb 24, 2021. Across all open-market trades the lifetime net is −$5.8M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
19
-$5.84M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) Delisted | Chief Scientific Officer | 22,828 | $129.46 | $2.96M | -$5.84M | 19 | 2021-02-24 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-24 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$476.6K | EDGAR |
| 2020-12-16 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$376.7K | EDGAR |
| 2020-10-08 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$284.7K | EDGAR |
| 2020-09-25 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$238.7K | EDGAR |
| 2020-06-23 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$192.7K | EDGAR |
| 2020-03-25 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −1,214 | -$63.7K | EDGAR |
| 2020-03-11 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −536 | -$27.9K | EDGAR |
| 2020-03-03 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2019-12-23 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$192.7K | EDGAR |
| 2019-06-19 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$284.7K | EDGAR |